Global Left Ventricular Assist Device (LVAD) Market Growth 2025-2031

The global Left Ventricular Assist Device (LVAD) market size is predicted to grow from US$ 3164 million in 2025 to US$ 7616 million in 2031; it is expected to grow at a CAGR of 15.8% from 2025 to 2031.

A left ventricular assist device (LVAD) is a pump that we use for patients who have reached end-stage heart failure.

AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart, etc. are the leaders of the industry, with high-end customers.

LP Information, Inc. (LPI) ' newest research report, the “Left Ventricular Assist Device (LVAD) Industry Forecast” looks at past sales and reviews total world Left Ventricular Assist Device (LVAD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Left Ventricular Assist Device (LVAD) sales for 2025 through 2031. With Left Ventricular Assist Device (LVAD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Left Ventricular Assist Device (LVAD) industry.

This Insight Report provides a comprehensive analysis of the global Left Ventricular Assist Device (LVAD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Left Ventricular Assist Device (LVAD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Left Ventricular Assist Device (LVAD) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Left Ventricular Assist Device (LVAD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Left Ventricular Assist Device (LVAD).

This report presents a comprehensive overview, market shares, and growth opportunities of Left Ventricular Assist Device (LVAD) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
BTT Therapy
Destination Therapy (DT)
Other

Segmentation by Application:
Hospitals
Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Jarvik Heart
Sun Medical Technology Research
ReliantHeart
Market Segment by Product Type
BTT Therapy
Destination Therapy (DT)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Left Ventricular Assist Device (LVAD) market?

What factors are driving Left Ventricular Assist Device (LVAD) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Left Ventricular Assist Device (LVAD) market opportunities vary by end market size?

How does Left Ventricular Assist Device (LVAD) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.